Interaction between Cryptococcus neoformans and alveolar macrophages

References

• Dupont, B, Graybill, JR, Armstrong, D, et al. Fungal infections in AIDs patients. J Med Vet Mycol 1992; 30(Suppl. 1)19–28
   PubMedGoogle Scholar
• Perfect JR, Durack DT, Gallis HA. Cryptococcemia. Medicine 1983; 62: 98–109
   PubMed Web of Science ®Google Scholar
• White MH, Armstrong D. Cryptococcosis. Infect Dis Clin North Am 1994; 8: 383–398
   PubMed Web of Science ®Google Scholar
• Hocking WG, Golde DW. The pulmonary-alveola marcophage. N Engl J Med 1979; 301: 580–587
   PubMed Web of Science ®Google Scholar
• Bolaños B, Mitchell TG. Phagocytosis of Cryptococcus neoformans by ratalveolar macrophages. J Med Vet Mycol 1989; 27: 203–217
   PubMedGoogle Scholar
• Bolaños B, Mitchell TG. Phagocytosis and killing of Cryptococcus neoformans by rat alevolar macrophages in the absence of serum. J Leukoc Biol 1989; 46: 521–528
   PubMed Web of Science ®Google Scholar
• Flesch IEA, Schwamberger G, Kaufmann SHE. Fungicidal activity of INF-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans. J Immunol 1989; 142: 3219–3224
   PubMed Web of Science ®Google Scholar
• Levitz SM, DiBenedetto DJ. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans. J Immunol 1989; 142: 659–665
   PubMed Web of Science ®Google Scholar
• Nyberg, K, Nessa, K, Johansson, A, et al. Alveolar macrophage response to yeasts and inert particles. J Med Vet Mycol 1996; 34: 11–17
   PubMedGoogle Scholar
• Wiernik A, Johansson A, Jarstrand C, Camner P. Rabbit lung after inhalation of soluble nickel. I. Effects on alveolar macrophages. Environ Res 1983; 30: 129–141
   PubMed Web of Science ®Google Scholar
• Hed J. The extinction of fluorescence by crystal violet and its use to differentiate between attached and ingested microorganisms in phagocytosis. FEMS Microbiol Lett 1977; 1: 357–361
   Web of Science ®Google Scholar
• Jarstrand C, Lundborg M, Wernik A, Camner P. Alveolar macrophage function in nickel dust exposed rabbits. Toxicology 1978; 11: 353–359
   PubMed Web of Science ®Google Scholar
• Nyberg K, Johansson U, Rundquist I, Camner P. Estimation of pH in individual alveolar macrophage phagolysosomes. Exp Lung Res 1989; 15: 499–510
   PubMed Web of Science ®Google Scholar
• Ohkuma S, Poole B. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci USA 1978; 75: 3327–3331
   PubMed Web of Science ®Google Scholar
• Goldman D, Lee SC, Casadevall A. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun 1994; 62: 4655–4761
   Web of Science ®Google Scholar
• Bulmer GS, Tacker JR. Phagocytosis of Cryptococcus neoformans by alveolar macrophages. Infect Immun 1975; 11: 73–79
   PubMed Web of Science ®Google Scholar
• Kozel TR, Gotschlich EC. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J Immunol 1982; 129: 1675–1680
   PubMed Web of Science ®Google Scholar
• Levitz SM. Macrophage-Cryptococcus interactions. Immunol Ser 1994; 60: 533–543
   PubMedGoogle Scholar
• Kozel TR. Opsonization and phagocytosis of Cryptococcus neoformans. Arch Med Res 1993; 24: 211–218
   PubMedGoogle Scholar
• Levitz, SM, Tabuni, A, Wagner, R, et al. Binding of unopsonized Cryptococcus neoformans by human bronchoalveolar macrophages: inhibition by a large molecular size serum component. J Infect Dis 1992; 166: 866–873
   PubMed Web of Science ®Google Scholar
• Weinberg PB, Becker S, Granger DL, Koren HS. Growth inhibition of Cryptococcus neoformans by human alveolar macrophages. Am Rev Respir Dis 1987; 136: 1242–1247
   PubMed Web of Science ®Google Scholar
• Vecchiarelli, A, Dottorini, M, Pietrella, D, et al. Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection. Am J Respir Cell Mol Biol 1994; 11: 130–137
   PubMed Web of Science ®Google Scholar
• Reynolds HY, Newball HH. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 1974; 84: 559–573
   PubMed Web of Science ®Google Scholar
• Robertson J, Caldwell JR, Castle JR, Waldman RH. Evidence for the presence of components of the alternative (properdin) pathway of complement activation in respiratory secretions. J Immunol 1976; 117: 900–903
   PubMed Web of Science ®Google Scholar
• Chakravarti B, Chakravarti DN. Phagocytosis: an overview. Pathol Immunopathol Res 1987; 6: 316–342
   PubMedGoogle Scholar
• Wright SD, Silverstein SC. Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J Exp Med 1983; 158: 2016–2023
   PubMed Web of Science ®Google Scholar
• Herting, E, Jarstrand, C, Rasool, O, et al. Effect of surfactant on nitroblue tetrazolium reduction of polymorphonuclear leucocytes stimulated with type la group B streptococci. Acta Paediatr 1995; 84: 922–926
   PubMed Web of Science ®Google Scholar
• Hidalgo HA, Helmke RJ, German VF, Mangos JA. Pneumocystis carinii induces an oxidative burst in alveolar macrophages. Infect Immun 1992; 60: 1–7
   PubMed Web of Science ®Google Scholar
• Kagaya, K, Yamada, T, Miyakawa, Y, et al. Characterization of pathogenic constituents of Cryptococcus neoformans strains. Microbiol Immunol 1985; 29: 517–532
   PubMed Web of Science ®Google Scholar